Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ALKEM LABORATORIES SANOFI INDIA/
ALKEM LABORATORIES
 
P/E (TTM) x 29.4 37.0 79.3% View Chart
P/BV x 14.6 6.4 226.3% View Chart
Dividend Yield % 7.4 1.0 723.2%  

Financials

 SANOFI INDIA   ALKEM LABORATORIES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-22
ALKEM LABORATORIES
Mar-23
SANOFI INDIA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs7,9393,625 219.0%   
Low Rs5,4542,835 192.4%   
Sales per share (Unadj.) Rs1,202.8970.1 124.0%  
Earnings per share (Unadj.) Rs269.584.2 320.0%  
Cash flow per share (Unadj.) Rs287.7110.2 261.1%  
Dividends per share (Unadj.) Rs570.0050.00 1,140.0%  
Avg Dividend yield %8.51.5 549.9%  
Book value per share (Unadj.) Rs527.0756.4 69.7%  
Shares outstanding (eoy) m23.03119.57 19.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.63.3 167.2%   
Avg P/E ratio x24.938.4 64.8%  
P/CF ratio (eoy) x23.329.3 79.4%  
Price / Book Value ratio x12.74.3 297.6%  
Dividend payout %211.559.4 356.2%   
Avg Mkt Cap Rs m154,224386,207 39.9%   
No. of employees `000NANA-   
Total wages/salary Rs m4,05921,314 19.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,701115,993 23.9%  
Other income Rs m7302,161 33.8%   
Total revenues Rs m28,431118,153 24.1%   
Gross profit Rs m8,34915,065 55.4%  
Depreciation Rs m4193,104 13.5%   
Interest Rs m171,074 1.6%   
Profit before tax Rs m8,64313,048 66.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4372,980 81.8%   
Profit after tax Rs m6,20610,068 61.6%  
Gross profit margin %30.113.0 232.1%  
Effective tax rate %28.222.8 123.5%   
Net profit margin %22.48.7 258.1%  
BALANCE SHEET DATA
Current assets Rs m36,12186,064 42.0%   
Current liabilities Rs m27,42537,071 74.0%   
Net working cap to sales %31.442.2 74.3%  
Current ratio x1.32.3 56.7%  
Inventory Days Days11733 358.1%  
Debtors Days Days1767 25.4%  
Net fixed assets Rs m12,14837,245 32.6%   
Share capital Rs m230239 96.2%   
"Free" reserves Rs m11,90690,208 13.2%   
Net worth Rs m12,13690,447 13.4%   
Long term debt Rs m00-   
Total assets Rs m48,279124,541 38.8%  
Interest coverage x509.413.2 3,872.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 61.6%   
Return on assets %12.98.9 144.1%  
Return on equity %51.111.1 459.4%  
Return on capital %71.415.6 457.0%  
Exports to sales %14.114.6 96.6%   
Imports to sales %14.60-   
Exports (fob) Rs m3,90416,916 23.1%   
Imports (cif) Rs m4,037NA-   
Fx inflow Rs m3,90416,916 23.1%   
Fx outflow Rs m4,0374,190 96.4%   
Net fx Rs m-13312,727 -1.0%   
CASH FLOW
From Operations Rs m3,98716,825 23.7%  
From Investments Rs m6,5091,128 576.8%  
From Financial Activity Rs m-15,827-17,608 89.9%  
Net Cashflow Rs m-5,331416 -1,280.9%  

Share Holding

Indian Promoters % 0.0 56.7 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 27.1 24.4 111.2%  
FIIs % 6.3 8.5 74.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 43.3 91.5%  
Shareholders   62,870 65,184 96.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Sanofi India vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs ALKEM LABORATORIES Share Price Performance

Period Sanofi India ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day -1.62% -2.09% -1.50%
1-Month -16.31% -10.92% -5.53%
1-Year 34.44% 56.81% 56.62%
3-Year CAGR -0.42% 22.88% 17.93%
5-Year CAGR 6.45% 22.31% 18.75%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of ALKEM LABORATORIES the stake stands at 56.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 570.0 per share. This amounted to a Dividend Payout ratio of 211.5%.

ALKEM LABORATORIES paid Rs 50.0, and its dividend payout ratio stood at 59.4%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.